EG1
CAS No. 693241-54-2
EG1 ( —— )
产品货号. M24706 CAS No. 693241-54-2
EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1199 | 有现货 |
|
10MG | ¥1831 | 有现货 |
|
25MG | ¥3686 | 有现货 |
|
50MG | ¥5443 | 有现货 |
|
100MG | ¥7671 | 有现货 |
|
500MG | ¥15309 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称EG1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
-
产品描述EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Pax2
-
研究领域——
-
适应症——
化学信息
-
CAS Number693241-54-2
-
分子量390.4
-
分子式C22H18N2O5
-
纯度>98% (HPLC)
-
溶解度DMSO:70mg/ml(179.31mM; need ultrasonic)
-
SMILESCOc(cccc1)c1C(Nc(cc1)ccc1C(Nc(cccc1)c1C(O)=O)=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Smith CB, Phillips T, Smith TJ. Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723. doi: 10.14694/EDBK_175474. PubMed PMID: 28561696.
产品手册
关联产品
-
Isonardosinone
Isonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF-?oB- and MAPK-mediated inflammatory pathways.
-
3,4,7,8-Tetramethoxy...
3',4',7,8-Tetramethoxyflavone has antioxidant activity.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.